Back to search
FDAFDA · Food and drugs·Recall number D-1556-2014

VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451.

Published September 3, 2014 · Recall initiated: March 4, 2014

Summary

FDA records drug Class II recall D-1556-2014, published September 3, 2014 and initiated March 4, 2014. Recalling firm: Alkermes, Inc.; Status: Terminated; Reported quantity: 4,364 vials; Lot: Batch Number: 412-3732AA; expiration date 07/2016 (NDC# 65757-302-02; Kit Pacaging Lot Number: 2013-021; expiration date 07/2016 (NDC# 65757-300-01. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Customer complaints for failure to deliver the dose.

What to do

Voluntary: Firm initiated · Letter

Get an email if VIVITROL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
VIVITROL
Manufacturer
Alkermes, Inc.
Distributor
Nationwide
Lot
Batch Number: 412-3732AA; expiration date 07/2016 (NDC# 65757-302-02; Kit Pacaging Lot Number: 2013-021; expiration date 07/2016 (NDC# 65757-300-01.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was VIVITROL (naltrexone for extended-release injectable suspension); 380 mg vial NDC 65757-300-01; RX Only Manufactured and marketed by Alkermes, Inc., Waltham, MA 02451. recalled?

Yes. FDA published recall D-1556-2014 on September 3, 2014. Reported hazard: Customer complaints for failure to deliver the dose.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: VIVITROL.